Wegovy vs Mounjaro: Which Prescription Weight Loss Treatment?
What Is Better Wegovy or Mounjaro for Prescription Weight Loss?
When comparing what is better Wegovy or Mounjaro for prescription weight loss, both treatments represent significant advances in obesity medicine as prescription-only medicines. Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics your body's natural fullness hormone, whilst Mounjaro uses tirzepatide, which targets both GIP and GLP-1 receptors simultaneously. This dual-action approach makes Mounjaro unique amongst current weight management treatments, though both require clinical assessment and ongoing medical supervision.
The question of what is better Wegovy or Mounjaro ultimately depends on individual patient factors including medical history, previous treatment responses, and lifestyle considerations. Both treatments must be used alongside a reduced-calorie diet and increased physical activity, and both show substantial weight loss in clinical trials when used as part of comprehensive weight management programmes. Your prescriber can evaluate which mechanism of action may be most suitable for your specific circumstances through EverydayMeds' clinical assessment process.
Wegovy vs Mounjaro Pricing and Value Comparison
Understanding what is better Wegovy or Mounjaro often involves considering treatment costs and accessibility. Wegovy pricing at EverydayMeds starts at £79.99 for the 0.25mg starter dose, progressing through £94.99 (0.5mg), £99.99 (1mg), £139.99 (1.7mg), to £209.99 for the 2.4mg maintenance dose. Our Getting Started bundles include the Intro Duo (0.25mg and 0.5mg pens) for £169.99, whilst the Ultimate Stability Trio provides three months of 2.4mg maintenance supply for £649.99.
Mounjaro pricing follows a different structure, though both treatments qualify for discount codes at checkout—new customers use FIRST40 whilst returning customers apply DOSE25. When evaluating what is better Wegovy or Mounjaro from a value perspective, consider that Wegovy's established supply chain and longer UK availability may offer more predictable access. Both treatments require gradual dose escalation over several months, making bundle options particularly convenient for ensuring continuous treatment without multiple orders.
Clinical Evidence: Wegovy and Mounjaro Weight Loss Studies
Clinical trials provide crucial insight when determining what is better Wegovy or Mounjaro for individual patients. The STEP programme demonstrated that patients taking Wegovy alongside diet and exercise achieved approximately 15% average weight loss at 68 weeks in STEP 1, compared to 2.4% with placebo. STEP 2 showed clinically studied weight loss in patients with type 2 diabetes, whilst STEP 3 achieved 16% with intensive behavioural therapy support.
Mounjaro's SURMOUNT trials showed impressive results with the dual-receptor approach, though directly comparing percentages between studies isn't appropriate due to different trial designs, populations, and endpoints. Both treatments demonstrate that substantial weight loss is possible when used as prescription-only medicines under medical supervision. The question of what is better Wegovy or Mounjaro should focus on which mechanism and side effect profile align best with your medical needs rather than trial-to-trial comparisons.
How Wegovy Works as a Prescription Weight Loss Treatment
Understanding what is better Wegovy or Mounjaro requires knowing how Wegovy functions as a GLP-1 receptor agonist. This prescription-only medicine mimics glucagon-like peptide-1, a hormone naturally released by your intestines after eating that signals fullness to your brain. Wegovy enhances this satiety response, helping you feel satisfied with smaller portions and reducing appetite between meals. The treatment also appears to influence food cravings by acting on appetite centres in the brain, though individual responses vary. Unlike simple appetite suppressants, Wegovy works with your body's existing hunger and fullness mechanisms rather than overriding them. This physiological approach explains why the treatment must be combined with dietary changes and physical activity to achieve optimal results in clinical practice.
EverydayMeds Ordering Process for Weight Loss Treatments
Starting your journey with either treatment begins with EverydayMeds' streamlined 3-minute online clinical assessment, designed to evaluate your suitability for prescription weight loss medication. Our qualified prescribers review your assessment within 3 working days (or 24 hours with express service), ensuring thorough medical evaluation before approving treatment. Once approved, we dispatch your medication via next-day delivery using temperature-controlled cold-chain logistics to maintain medication integrity. This process applies whether you're wondering what is better Wegovy or Mounjaro, as both require identical clinical oversight and pharmaceutical handling. Our GPhC-registered pharmacy (#9012878) ensures all treatments meet UK regulatory standards for prescription-only medicines throughout the supply chain.
Storage and Practical Considerations: Wegovy vs Mounjaro
Practical factors often influence decisions about what is better Wegovy or Mounjaro for individual lifestyles. Wegovy requires refrigerated storage at 2-8°C before first use but offers a significant travel advantage—once removed from the fridge, Wegovy pens remain stable at room temperature (below 30°C) for up to 6 weeks. This compares favourably to Mounjaro's 21-day room temperature limit, making Wegovy more convenient for extended travel or unpredictable schedules. Both treatments use pre-filled injection pens (Wegovy's FlexTouch system is particularly user-friendly), require weekly injections on the same day each week, and follow mandatory dose escalation schedules that cannot be rushed. The longer room temperature stability often tips the balance when patients are deciding what is better Wegovy or Mounjaro for their circumstances.
Why Both Treatments Excel in Different Patient Populations
Rather than definitively answering what is better Wegovy or Mounjaro, experienced prescribers recognise that patient-specific factors determine optimal treatment choice. Wegovy's established track record and single-mechanism approach may suit patients who prefer treatments with longer real-world experience and extensive safety data. The 6-week room temperature stability particularly benefits frequent travellers or those with unpredictable refrigerator access.
Mounjaro's dual-receptor mechanism appeals to patients whose previous weight loss attempts suggest they might benefit from the additional GIP pathway activation. Some patients respond better to one mechanism over the other, which is why both remain valuable options in prescription weight loss treatment. The question of what is better Wegovy or Mounjaro ultimately becomes academic when your prescriber can help identify which mechanism aligns with your physiology, lifestyle, and treatment history.
Start Your Prescription Weight Loss Journey Today
Both Wegovy and Mounjaro represent proven approaches to prescription weight loss, each offering unique advantages depending on your circumstances. Rather than continuing to wonder what is better Wegovy or Mounjaro, take our comprehensive clinical assessment to determine your suitability for either treatment. New customers can apply discount code FIRST40 at checkout, whilst returning customers use DOSE25 to access our competitive pricing. Our qualified prescribers will evaluate your medical history, current medications, and weight loss goals to recommend the most appropriate treatment. Visit https://everydaymeds.co.uk/collections/wegovy to begin your assessment and discover which prescription weight loss option best suits your needs. Both treatments are available with next-day delivery once approved, ensuring you can start your weight management journey without delay.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
